HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2025)
HUTCHMED (China) (HCM) reported Other Non-Current Assets of $10.3 million for Q4 2025, up 114.65% year-over-year from $4.8 million in Q4 2024, and down 74.59% quarter-over-quarter from $40.6 million in Q2 2025.
HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Other Non-Current Assets data on file, last reported at $10.3 million in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $10.3 million, up 114.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.3 million (up 114.65% YoY), and the FY2025 annual result was $20.1 million, up 1526.99% from the prior year.
- Other Non-Current Assets declined to $10.3 million in Q4 2025 per HCM's latest filing, from $40.6 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $4.5 billion in Q4 2023 and troughed at $4.8 million in Q2 2024.
- A 5-year average of $423.7 million and a median of $24.7 million in 2021 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 87351.98% in 2023, then sank 99.89% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $5.5 million in 2021, then fell by 7.39% to $5.1 million in 2022, then jumped by 87351.98% to $4.5 billion in 2023, then slumped by 99.89% to $4.8 million in 2024, then soared by 114.65% to $10.3 million in 2025.
- Business Quant data shows HCM's Other Non-Current Assets at $10.3 million in Q4 2025, $40.6 million in Q2 2025, and $4.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | 10.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.32 Mn |
| Jun 30, 2025 | 40.62 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Jun 30, 2024 | 4.77 Mn |
| Dec 31, 2023 | 4.45 Bn |
| Jun 30, 2023 | 39.55 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Jun 30, 2022 | 45.04 Mn |
| Dec 31, 2021 | 5.50 Mn |
| Jun 30, 2021 | 24.71 Mn |
| Mar 31, 2021 | 26.97 Mn |
| Dec 31, 2020 | 20.17 Mn |
| Jun 30, 2020 | 6.64 Mn |
| Dec 31, 2019 | 5.78 Mn |
| Sep 30, 2019 | 6.58 Mn |
| Jun 30, 2019 | 6.77 Mn |
| Mar 31, 2019 | 6.77 Mn |
| Dec 31, 2018 | 292,000.00 |
| Jun 30, 2018 | 6.58 Mn |
| Dec 31, 2017 | 1.65 Mn |